Tyra Biosciences CEO Todd Harris sold 10,035 shares on Oct 15 and 15,394 shares on Oct 17.

Tyra Biosciences CEO Todd Harris sold 10,035 shares on October 15 for approximately $243,950, following previous sales in recent months. On October 17, he sold an additional 15,394 shares for about $397,935, leaving him with 1,418,647 shares. The company, focused on precision medicines for FGFR biology, recently reported an EPS of ($0.32), exceeding analyst expectations. TYRA shares rose to $25.98 during trading.